英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：

innermost    音标拼音: ['ɪnɚm,ost]
a. 最里面的;最深处的
n. 最深处

最里面的;最深处的最深处

innermost
adj 1: being deepest within the self; "one's innermost feelings"
[synonym: {inmost}, {innermost}]
2: situated or occurring farthest within; "the innermost
chamber" [synonym: {inmost}, {innermost}]

Innermost \In"ner*most`\ ([i^]n"n[~e]r*m[=o]st`), a. [A
corruption of inmost due to influence of inner. See
{Inmost}.]
Farthest inward; most remote from the outward part; inmost;
deepest within. --Prov. xviii. 8.
[1913 Webster]


请选择你想看的字典辞典：
单词字典翻译
innermost查看　innermost　在百度字典中的解释百度英翻中〔查看〕
innermost查看　innermost　在Google字典中的解释Google英翻中〔查看〕
innermost查看　innermost　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Spyglass Pharma, Inc. (SGP) 8-K Earnings Release - Mar 2026
    Spyglass Pharma, Inc (SGP) SEC Filing 8-K Material Event for the period ending Thursday, March 26, 2026
  • SGP Press Release: SpyGlass Pharma Reports Fourth Quarter and . . .
    Read Press Release for Spyglass Pharma (SGP) published on Mar 26, 2026 - SpyGlass Pharma Reports Fourth Quarter and Full Year 2025 Earnings and Provides a Corporate Update
  • SpyGlass Pharma’s BIM-IOL System: Transforming Glaucoma and . . .
    SpyGlass Pharma, Inc 2025 Annual Report: Key Points and Investor Analysis SpyGlass Pharma, Inc 2025 Annual Report: Essential Highlights and Shareholder Updates Overview SpyGlass Pharma, Inc (Nasdaq: SGP) has released its annual report for the fiscal year ended December 31, 2025 This report contains numerous details of strategic importance for shareholders, including financial, operational
  • SpyGlass Pharma Reports Fourth Quarter and Full Year 2025 . . .
    --SpyGlass Pharma, Inc , a late-stage biopharmaceutical company, today reported recent business highlights and financial results for the fourth quarter and year ended December 31, 2025 We look
  • SpyGlass Pharma Reports Fourth Quarter and Full Year 2025 . . .
    These forward-looking statements are neither promises nor guarantees and are subject to a variety of risks and uncertainties, including those set forth in the Risk Factors section of the Company’s annual report on Form 10-K for the fiscal year ended December 31, 2025 filed with the Securities and Exchange Commission on or about the date
  • Stockwatch
    ALISO VIEJO, Calif , March 26, 2026 (GLOBE NEWSWIRE) -- SpyGlass Pharma, Inc (Nasdaq: SGP) (“SpyGlass Pharma” or “Company”), a late-stage biopharmaceutical company, today reported recent business highlights and financial results for the fourth quarter and year ended December 31, 2025
  • www. sg-tea. com
    www sg-tea com
  • SEC. gov
    We nonetheless reserve the right to make such updates from time to time by press release, periodic report or other method of public disclosure without the need for specific reference to this financial outlook
  • Company Information - Philippine Stock Exchange
    On December 20, 2019, SGP entered into a share swap transaction with the stockholders of OneTaipan Holdings, Inc (OTHI) and Pacifica2 Holdings, Inc (P21) As a result, SGP owned 67% of the outstanding shares of each OTHI and P21





中文字典-英文字典  2005-2009